Resynchronization Surgery Combined Unified Efficacy

PHASE3CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Ischemic Heart Failure
Interventions
PROCEDURE

Coronary artery bypass grafting

Standard coronary surgry according guidelines

DEVICE

Epicardial implantation of cardiac resynchronization therapy device

During the cardiac surgery, the CABG+CRT arm patients will be implanted with epicardial leads to the right atrium, right and left ventricles. Left ventricle leads will be fixed to the posterolateral wall provided that there is no scar or fat tissue (behind and 2-3 cm apical than obtuse marginal artery). Right atrial and right ventricular leads will be fixed in a traditional way. Then the leads will be guided into a preformed pocket (left subclavian region) and connected with the CRT device.

Trial Locations (3)

630055

State Research Institute of Circulation Pathology, Novosibirsk

Unknown

Medical University of Silesia, Katowice

University Medical Center, Ljubljana

All Listed Sponsors
collaborator

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

lead

Meshalkin Research Institute of Pathology of Circulation

NETWORK

NCT00846001 - Resynchronization Surgery Combined Unified Efficacy | Biotech Hunter | Biotech Hunter